Stocktoria
Forte Biosciences, Inc. FBRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-04-13
Forte Biosciences, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Riley Antony A | CHIEF FINANCIAL OFFICER | 2026-04-01 | Option exercise | 375 | — |
| Riley Antony A | CHIEF FINANCIAL OFFICER | 2026-04-01 | Tax withheld | 134 | $24.86 |
| Wagner Paul A. | SEE REMARKS | 2026-04-01 | Option exercise | 1,250 | — |
| Wagner Paul A. | SEE REMARKS | 2026-04-01 | Tax withheld | 98 | $24.86 |
Source: SEC EDGAR filings · CIK 0001419041 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.